momelotinib dihydrochloride monohydrate
SpainDrugs containing this active substance
-
It is used to treat adult patients with myelofibrosis (a type of blood cancer) who present with increased spleen size or other related symptoms, and who also have moderate to severe anemia.
Form: tablets, film-coated
Active substance Dosage momelotinib dihydrochloride monohydrate 121,94 mg Manufacturer: Glaxosmithkline Trading Services Limited
-
It is used to treat adult patients with myelofibrosis (a type of blood cancer) who present with an enlarged spleen or other related symptoms, and who also suffer from moderate to severe anemia.
Form: tablets, film-coated
Active substance Dosage momelotinib dihydrochloride monohydrate 182,91 mg Manufacturer: Glaxosmithkline Trading Services Limited
-
It is used to treat adult patients with myelofibrosis (a type of blood cancer) who present with an enlarged spleen or other related symptoms, and who also suffer from moderate to severe anemia.
Form: tablets, film-coated
Active substance Dosage momelotinib dihydrochloride monohydrate 243,88 mg Manufacturer: Glaxosmithkline Trading Services Limited